The Ministry of Human Resources and Social Security (MOHRSS) today announced the results of the national health insurance negotiations, and two GSK products, Tykerb (Lapatinib) and Seroxat CR (Paroxetine), are included in the national reimbursement drug list (NRDL).
These press releases are intended for business journalists and analysts/investors
GSK announces strategic partnership with academia to co-develop health big-data system and upgrade the management of respiratory diseases
The programme will cover 5000 COPD patients and 60,000 athma patients.
The National Preventive Vaccination Services and Management Training Programme, helmed by the Chinese Preventive Medicine Association under the guidance of the National Health and Family Planning Commission (hereinafter referred to as NHFPC), with the support of the China Centre for Disease Control and Prevention and the aid of GSK, was officially kicked off today.